We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Global Advanced Wound-Management Market Experiences Growth

By HospiMedica International staff writers
Posted on 24 Nov 2009
A new report by GlobalData (London, United Kingdom) identifies and assesses the key trends shaping and driving the global advanced wound management market. More...


According to GlobalData, the global advanced wound management market was valued at U.S. $3.6 billion in 2008 and forecasts that it will grow by 4.7% annually for the next seven years, reaching $5 billion by 2015. This growth will primarily be driven by an increase in the incidence of chronic wounds such as venous, diabetic, and pressure ulcers, increased patient awareness, and technology advancement in the products themselves.

Foams and hydrofibers remain the key market segments that are driving growth within the advanced wound management market; together, these two segments accounted for 67% of the overall advanced wound management market in 2008. According to the report, the foams market is forecast to grow at a 5.4% compound annual growth rate (CAGR) till 2015, due to faster healing of certain types of wounds and reduced patient follow-up, which will limit the cost factor. The hydrofibers market is forecast to grow at 4.7% CAGR, and is expected to be driven by technological advancements and an increase in the number of diabetic patients.

Globally, the United States remains the largest advanced wound management market, and is expected to continue to be so. The U.S. market was valued at $1.5 billion in 2008 and is forecast to grow at a 4.9% CAGR, reaching a value of $2.2 billion by 2015. The U.S. market is expected to be driven by a growing chronic wound population and increased levels of patient awareness. Companies such as Smith & Nephew, Molnlycke Healthcare, Convatec, and Covidien remain the leading competitors in the global advanced wound management market; together, these companies accounted for 56% of the global market share in 2008, with Smith & Nephew (London, United Kingdom) the market leader with a share of 27%. However, with more than 35 products in different developmental stages in 2008, and many of these expected to hit the market in the next few years, a shift in the prevailing competitive landscape cannot be ruled out. If approved, these pipeline products could lead to an intensely competitive market landscape, and the existing market leaders need to be prepared to manage these future challenges.

Related Links:
GlobalData
Smith & Nephew


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Adjustable Mobile Barrier
M-458
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.